Marketing-authorisation holder · Italy
Kedrion S.P.A.
47 medicines in 7 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
47 medicines in 7 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 47
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AIMAFIXPolvere e solvente per soluzione per infusione endovenosa | Coagulation factor ix | Italy | Authorised | |
| ALBITALSoluzione per infusione | Albumin | Italy | Authorised | |
| AT III KEDRIONPolvere e solvente per soluzione per infusione endovenosa | Antithrombin iii | Italy | Authorised | |
| ATKEDPolvere e solvente per soluzione per infusione endovenosa | Antithrombin iii | Italy | Authorised | |
| COAGADEXPolvere e solvente per soluzione iniettabile | Coagulation factor x | Italy | Authorised | |
| Coagadex | Coagulation factor x | EU (EMA) | Authorised | 2016 |
| Coagadex 100 IU/ml, poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Coagulation factor x | Netherlands | Authorised | 2016 |
| COAGADEX 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE250 ui · Polvo y disolvente para solución inyectable | Factor x | Spain | Authorised | 2025 |
| COAGADEX 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE500 ui · Polvo y disolvente para solución inyectable | Factor x | Spain | Marketed | 2025 |
| EMOCLOTPolvere e solvente per soluzione per infusione endovenosa | Antihemophilic factor | Italy | Authorised | |
| Emoclot 100 IU/ml prašak i otapalo za otopinu za injekciju/infuzijuPrašak i otapalo za otopinu za injekciju / infuziju | Antihemophilic factor | Croatia | Marketed | 2017 |
| Emoclot 50 IU/ml prašak i otapalo za otopinu za injekciju/infuzijuPrašak i otapalo za otopinu za injekciju / infuziju | Antihemophilic factor | Croatia | Marketed | 2017 |
| EMOSINTSoluzione iniettabile | Desmopressin | Italy | Authorised | |
| EMOWILPolvere e solvente per soluzione iniettabile | Antihemophilic factor | Italy | Authorised | |
| Human albumin Kedrion 200 g/l otopina za infuzijuotopina za infuziju | Albumin | Croatia | Marketed | 2017 |
| IG VENASoluzione per infusione | Immunoglobulina umana normale | Italy | Authorised | |
| Ig Vena 50 g/l otopina za infuzijuotopina za infuziju | Imunoglobulin normalni, ljudski, intravenski | Croatia | Marketed | 2018 |
| IG VENA 50 G/L SOLUCION PARA PERFUSION50 mg · Solución para perfusión | Inmunoglobulina humana normal | Spain | Marketed | 2023 |
| IMMUNOHBSSoluzione iniettabile | Hepatitis b immunoglobulin | Italy | Authorised | |
| IMMUNORHOPolvere e solvente per soluzione iniettabile | Anti-d (rh) immunoglobulin | Italy | Authorised | |
| IXEDPolvere e solvente per soluzione per infusione endovenosa | Coagulation factor ix | Italy | Authorised | |
| KEDCOMPolvere e solvente per soluzione per infusione endovenosa | Complesso protrombinico umano | Italy | Authorised | |
| KEDHBSSoluzione iniettabile | Hepatitis b immunoglobulin | Italy | Authorised | |
| KEYCUTESoluzione per infusione | Immunoglobulina umana normale | Italy | Authorised | |
| KLOTTPolvere e solvente per soluzione per infusione endovenosa | Antihemophilic factor | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 27 | 27 | 0 | CompaniesAll medicines |
| Romania | 7 | 0 | 7 | CompaniesAll medicines |
| Croatia | 5 | 5 | 0 | CompaniesAll medicines |
| Spain | 3 | 3 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.